BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 2005467)

  • 1. Effects of MK-329 on gastric emptying of solids in cats.
    Hornof WJ; Koblik PD
    J Nucl Med; 1991 Mar; 32(3):547-8. PubMed ID: 2005467
    [No Abstract]   [Full Text] [Related]  

  • 2. A model of gastric emptying in cats shows solid emptying is promoted by MK-329: a CCK antagonist.
    Gould RJ; Fioravanti C; Cook PG; Solomon HF
    J Nucl Med; 1990 Sep; 31(9):1494-9. PubMed ID: 2203881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cholecystokinin in gastric emptying of liquid and solid meals in dogs.
    Cheng S; Novich K; Sankaran H; Deveney CW
    Curr Surg; 1990; 47(6):433-5. PubMed ID: 2279401
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cholecystokinin and its antagonists: effects on digestive motility].
    Bruley des Varannes S; Cloarec D; Dubois A; Galmiche JP
    Gastroenterol Clin Biol; 1991; 15(10):744-57. PubMed ID: 1816015
    [No Abstract]   [Full Text] [Related]  

  • 5. Voluntary intake and gastric emptying in pigs: effects of fat and a CCK inhibitor.
    Rayner DV; Miller S
    Physiol Behav; 1993 Nov; 54(5):917-22. PubMed ID: 8248383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of metoclopramide, bethanechol and the cholecystokinin receptor antagonist, L-364,718, on gastric emptying in the rat.
    Decktor DL; Pendleton RG; Elnitsky AT; Jenkins AM; McDowell AP
    Eur J Pharmacol; 1988 Mar; 147(2):313-6. PubMed ID: 3366182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.
    Lotti VJ; Pendleton RG; Gould RJ; Hanson HM; Chang RS; Clineschmidt BV
    J Pharmacol Exp Ther; 1987 Apr; 241(1):103-9. PubMed ID: 2437282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the cholecystokinin antagonist devazepide (L364718) on the ileal brake mechanism in the rat.
    Brown NJ; Rumsey RD; Read NW
    J Pharm Pharmacol; 1993 Dec; 45(12):1033-6. PubMed ID: 7908970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous cholecystokinin in the control of gastric emptying of liquid nutrient loads in rhesus monkeys.
    Moran TH; Ameglio PJ; Schwartz GJ; Peyton HJ; McHugh PR
    Am J Physiol; 1993 Aug; 265(2 Pt 2):R371-5. PubMed ID: 8368391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CGRP 8-37[correction of 8-27] blocks the inhibition of gastric emptying induced by intravenous injection of alpha-CGRP in rats.
    Plourde V; St-Pierre S; Fournier A; Taché Y
    Life Sci; 1993; 52(10):857-62. PubMed ID: 8383261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist.
    Pendleton RG; Bendesky RJ; Schaffer L; Nolan TE; Gould RJ; Clineschmidt BV
    J Pharmacol Exp Ther; 1987 Apr; 241(1):110-6. PubMed ID: 2437283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous CCK in the control of gastric emptying of glucose and maltose.
    Moran TH; Field DG; Knipp S; Carrigan TS; Schwartz GJ
    Peptides; 1997; 18(4):547-50. PubMed ID: 9210174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MK-329 has no direct effect on the pancreas.
    Berlin RG
    Gastroenterology; 1989 Aug; 97(2):553-4. PubMed ID: 2744367
    [No Abstract]   [Full Text] [Related]  

  • 14. A non-invasive method for measurement of gastric emptying in mice: effects of altering fat content and CCK A receptor blockade.
    Whited KL; Hornof WJ; Garcia T; Bohan DC; Larson RF; Raybould HE
    Neurogastroenterol Motil; 2004 Aug; 16(4):421-7. PubMed ID: 15305997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cholecystokinin receptor antagonist devazepide enhances morphine-induced analgesia but not morphine-induced respiratory depression in the squirrel monkey.
    Dourish CT; O'Neill MF; Schaffer LW; Siegl PK; Iversen SD
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1158-65. PubMed ID: 2262899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist.
    Wolkowitz OM; Gertz B; Weingartner H; Beccaria L; Thompson K; Liddle RA
    Biol Psychiatry; 1990 Jul; 28(2):169-73. PubMed ID: 2378921
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of cholecystokinin in the gastric motor response to a meal in horses.
    Lorenzo-Figueras M; Merritt AM
    Am J Vet Res; 2006 Dec; 67(12):1998-2005. PubMed ID: 17144800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of benzodiazepines, including diazepam, clonazepam, Ro 5-4864 and devazepide, on lindane-induced toxicity.
    Woolley DE
    Proc West Pharmacol Soc; 1994; 37():131-4. PubMed ID: 7527152
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastric emptying.
    Malmud LS; Vitti RA
    J Nucl Med; 1990 Sep; 31(9):1499-500. PubMed ID: 2395018
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo modulation of cisplatin cytotoxicity by the cholecystokinin antagonist MK-329 in human pancreatic cancer xenografts.
    Jamshidipour R; Pinho EB; Howell SB
    Anticancer Res; 1994; 14(6B):2611-6. PubMed ID: 7872689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.